var data={"title":"Unique aspects of gastrointestinal disease in dialysis patients","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Unique aspects of gastrointestinal disease in dialysis patients</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/contributors\" class=\"contributor contributor_credentials\">Thomas A Golper, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/contributors\" class=\"contributor contributor_credentials\">Lawrence S Friedman, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/contributors\" class=\"contributor contributor_credentials\">Jeffrey S Berns, MD</a></dd><dt><span> </span>Deputy Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/contributors\" class=\"contributor contributor_credentials\">Alice M Sheridan, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/contributors\" class=\"contributor contributor_credentials\">Shilpa Grover, MD, MPH, AGAF</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Dec 06, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Gastrointestinal (GI) symptoms are reported in up to 80 percent of dialysis patients [<a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/1-3\" class=\"abstract_t\">1-3</a>]. This topic reviews GI disorders that occur with a higher prevalence or have clinical features that are unique dialysis patients. We also discuss management considerations that are specific to GI diseases in patients on dialysis.</p><p class=\"headingAnchor\" id=\"H1670291988\"><span class=\"h1\">ESOPHAGUS AND STOMACH</span></p><p class=\"headingAnchor\" id=\"H2568298620\"><span class=\"h2\">Angiodysplasia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Angiodysplasias are the most common vascular anomalies encountered in the GI tract. While their presentation and management are in most respects similar to the non-end-stage renal disease (ESRD) population, patients with ESRD and chronic GI bleeding may benefit from estrogen therapy.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Prevalence</strong> &ndash; Angiodysplasias account for approximately 20 and 30 percent of episodes of upper and lower GI bleeding, respectively, and for approximately one-half of recurrent episodes of upper GI bleeding in patients with ESRD [<a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/4\" class=\"abstract_t\">4</a>]. It is unclear if the prevalence of angiodysplasia is higher among ESRD patients as compared with the general population or if angiodysplastic lesions are detected more frequently in patients on hemodialysis due to exposure to anticoagulants and uremia-induced platelet dysfunction [<a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/4-7\" class=\"abstract_t\">4-7</a>]. (See <a href=\"topic.htm?path=angiodysplasia-of-the-gastrointestinal-tract\" class=\"medical medical_review\">&quot;Angiodysplasia of the gastrointestinal tract&quot;</a> and <a href=\"topic.htm?path=angiodysplasia-of-the-gastrointestinal-tract#H5\" class=\"medical medical_review\">&quot;Angiodysplasia of the gastrointestinal tract&quot;, section on 'End-stage renal disease'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Clinical presentation and diagnosis &ndash;</strong> Patients usually present with chronic GI bleeding, although severe acute bleeding may also occur. Angiodysplastic lesions may also be found incidentally during endoscopic evaluation performed for other indications. The clinical presentation and diagnosis of angiodysplasia of the GI tract are discussed elsewhere. (See <a href=\"topic.htm?path=angiodysplasia-of-the-gastrointestinal-tract#H13\" class=\"medical medical_review\">&quot;Angiodysplasia of the gastrointestinal tract&quot;, section on 'Clinical manifestations'</a> and <a href=\"topic.htm?path=angiodysplasia-of-the-gastrointestinal-tract#H17\" class=\"medical medical_review\">&quot;Angiodysplasia of the gastrointestinal tract&quot;, section on 'Diagnosis'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Management</strong> &ndash; Dialysis patients with chronic GI bleeding can benefit from administration of conjugated estrogens. Small case series have suggested that estrogens may prevent recurrent bleeding from angiodysplasia and reduce transfusion requirements [<a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/8,9\" class=\"abstract_t\">8,9</a>]. The management of GI bleeding in dialysis patients is otherwise similar to nondialysis patients and is discussed in detail separately. (See <a href=\"topic.htm?path=approach-to-acute-upper-gastrointestinal-bleeding-in-adults\" class=\"medical medical_review\">&quot;Approach to acute upper gastrointestinal bleeding in adults&quot;</a> and <a href=\"topic.htm?path=platelet-dysfunction-in-uremia#H12\" class=\"medical medical_review\">&quot;Platelet dysfunction in uremia&quot;, section on 'Estrogen'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H4145135415\"><span class=\"h2\">Esophageal varices</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Hemodialysis patients can rarely develop varices in the upper esophagus. These &quot;downhill&quot; esophageal varices, named after their downward direction of blood flow, result from superior vena cava (SVC) obstruction due to upper-extremity hemodialysis access [<a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/10-12\" class=\"abstract_t\">10-12</a>]. Patients may be asymptomatic and discovered incidentally or present with upper GI bleeding. Definitive management involves treatment of the underlying SVC obstruction. However, in patients with severe upper GI bleeding, endoscopic therapy with variceal band ligation or sclerotherapy at the proximal end of the varix to temporize bleeding may be required prior to definitive treatment. (See <a href=\"topic.htm?path=malignancy-related-superior-vena-cava-syndrome\" class=\"medical medical_review\">&quot;Malignancy-related superior vena cava syndrome&quot;</a> and <a href=\"topic.htm?path=central-vein-stenosis-associated-with-hemodialysis-access\" class=\"medical medical_review\">&quot;Central vein stenosis associated with hemodialysis access&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H980967562\"><span class=\"h2\">Gastroparesis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with ESRD are more likely to have gastroparesis; symptoms overlap with uremia. Typically, dialysis is optimized prior to extensive work-up and management of gastroparesis.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Epidemiology</strong> &ndash; The prevalence of gastroparesis (delayed gastric emptying) in ESRD is higher as compared with the general population, possibly due to a higher prevalence of diabetes and the use of medications that can affect gastric emptying [<a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/3,13,14\" class=\"abstract_t\">3,13,14</a>]. In peritoneal dialysis patients, mechanical or neurogenic mechanisms triggered by the presence of intra-abdominal fluid have been implicated in delayed gastric emptying. (See <a href=\"topic.htm?path=noninfectious-complications-of-continuous-peritoneal-dialysis\" class=\"medical medical_review\">&quot;Noninfectious complications of continuous peritoneal dialysis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Clinical</strong> <strong>presentation</strong> &ndash; Undiagnosed gastroparesis is an important cause of malnutrition in patients with ESRD [<a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/15\" class=\"abstract_t\">15</a>]. Similar to nondialysis patients, patients with ESRD and gastroparesis can present with nausea, vomiting, abdominal pain, early satiety, postprandial fullness, bloating, and, in severe cases, weight loss. (See <a href=\"topic.htm?path=gastroparesis-etiology-clinical-manifestations-and-diagnosis#H259165581\" class=\"medical medical_review\">&quot;Gastroparesis: Etiology, clinical manifestations, and diagnosis&quot;, section on 'Clinical manifestations'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Diagnosis</strong> &ndash; As symptoms of gastroparesis, particularly early satiety, nausea, and vomiting, are similar to those of uremia, the dialysis prescription and delivered dialysis dose should be assessed prior to performing an extensive evaluation for gastroparesis. In addition, all medications should be carefully reviewed and culprit medications discontinued where possible. As an example, iron supplements frequently cause abdominal pain. Phosphate binders, alkali replacement in the form of sodium citrate or <a href=\"topic.htm?path=sodium-bicarbonate-drug-information\" class=\"drug drug_general\">sodium bicarbonate</a>, and some antihypertensive medications (eg, calcium channel blockers, <a href=\"topic.htm?path=clonidine-drug-information\" class=\"drug drug_general\">clonidine</a>) may cause nausea. The diagnostic evaluation for gastroparesis is the same as in the nondialysis population and is discussed separately. (See <a href=\"topic.htm?path=gastroparesis-etiology-clinical-manifestations-and-diagnosis#H859989\" class=\"medical medical_review\">&quot;Gastroparesis: Etiology, clinical manifestations, and diagnosis&quot;, section on 'Diagnosis'</a> and <a href=\"topic.htm?path=indications-for-initiation-of-dialysis-in-chronic-kidney-disease#H1147970498\" class=\"medical medical_review\">&quot;Indications for initiation of dialysis in chronic kidney disease&quot;, section on 'Common indications'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Management</strong> &ndash; The management of gastroparesis is presented elsewhere. (See <a href=\"topic.htm?path=treatment-of-gastroparesis\" class=\"medical medical_review\">&quot;Treatment of gastroparesis&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H2869713521\"><span class=\"h1\">PANCREAS</span></p><p class=\"headingAnchor\" id=\"H695430209\"><span class=\"h2\">Acute pancreatitis</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Epidemiology and risk factors</strong> &ndash; The risk of acute pancreatitis is higher among dialysis patients as compared with the general population [<a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/16-21\" class=\"abstract_t\">16-21</a>]. In a retrospective cohort study of 67,078 patients with end-stage renal disease (ESRD), the cumulative incidence of acute pancreatitis at one, three, five, seven, and nine years after initiating dialysis was 0.6, 1.7, 2.6, 3.4, and 4 percent, respectively [<a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/16\" class=\"abstract_t\">16</a>]. The risk of acute pancreatitis was higher among patients undergoing peritoneal dialysis as compared with hemodialysis (5.11 and 5.86 per 1000 person-years).</p><p/><p class=\"bulletIndent1\">The etiology of acute pancreatitis in dialysis patients is similar to nondialysis patients. However, some risk factors may be more prevalent in dialysis patients (eg, hypercalcemia due to hyperparathyroidism) [<a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/17,20,22-25\" class=\"abstract_t\">17,20,22-25</a>] (see <a href=\"topic.htm?path=etiology-of-acute-pancreatitis\" class=\"medical medical_review\">&quot;Etiology of acute pancreatitis&quot;</a>). The risk of acute pancreatitis may be increased among peritoneal dialysis patients by chronic exposure to specific dialysate solutions. <a href=\"topic.htm?path=icodextrin-drug-information\" class=\"drug drug_general\">Icodextrin</a> has been associated with acute pancreatitis in a number of case reports [<a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/25-27\" class=\"abstract_t\">25-27</a>]. High dextrose-containing dialysate (ie, 4.25 percent) may also be associated with pancreatitis [<a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/18-20\" class=\"abstract_t\">18-20</a>]. (See <a href=\"topic.htm?path=peritoneal-dialysis-solutions#H3\" class=\"medical medical_review\">&quot;Peritoneal dialysis solutions&quot;, section on 'Constituents'</a>.)</p><p/><p class=\"bulletIndent1\">Although dyslipidemia is highly prevalent in patients with renal disease, triglyceride concentrations that are high enough to cause acute pancreatitis (&gt;1000 <span class=\"nowrap\">mg/dL)</span> are rare. (See <a href=\"topic.htm?path=etiology-of-acute-pancreatitis\" class=\"medical medical_review\">&quot;Etiology of acute pancreatitis&quot;</a> and <a href=\"topic.htm?path=hypertriglyceridemia-induced-acute-pancreatitis\" class=\"medical medical_review\">&quot;Hypertriglyceridemia-induced acute pancreatitis&quot;</a> and <a href=\"topic.htm?path=overview-of-the-management-of-chronic-kidney-disease-in-adults\" class=\"medical medical_review\">&quot;Overview of the management of chronic kidney disease in adults&quot;</a> and <a href=\"topic.htm?path=overview-of-the-management-of-chronic-kidney-disease-in-adults#H20\" class=\"medical medical_review\">&quot;Overview of the management of chronic kidney disease in adults&quot;, section on 'Dyslipidemia'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Clinical</strong> <strong>presentation</strong> <strong>and</strong> <strong>diagnosis</strong> &ndash; The symptoms of acute pancreatitis in hemodialysis patients are similar to those in patients without renal failure. Serum concentrations of pancreatic amylase and lipase are elevated in patients with ESRD in the absence of acute pancreatitis. However, the absolute values generally do not exceed three times the upper limit of normal. Among peritoneal dialysis patients, it is important to differentiate acute pancreatitis from microbial peritonitis. The clinical presentation and diagnosis of acute pancreatitis and microbial peritonitis are discussed elsewhere. (See <a href=\"topic.htm?path=serum-enzymes-in-patients-with-renal-failure#H6\" class=\"medical medical_review\">&quot;Serum enzymes in patients with renal failure&quot;, section on 'Pancreatic enzymes'</a> and <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-acute-pancreatitis#H26225963\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of acute pancreatitis&quot;, section on 'Diagnosis'</a> and <a href=\"topic.htm?path=approach-to-the-patient-with-elevated-serum-amylase-or-lipase\" class=\"medical medical_review\">&quot;Approach to the patient with elevated serum amylase or lipase&quot;</a> and <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-peritonitis-in-peritoneal-dialysis#H12\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of peritonitis in peritoneal dialysis&quot;, section on 'Differential diagnosis'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Management</strong> &ndash; We use minimal heparin among hemodialysis patients with acute pancreatitis to reduce the theoretical risk of the hemorrhagic pancreatitis.</p><p/><p class=\"bulletIndent1\">Peritoneal dialysis should not routinely be discontinued in all patients with acute pancreatitis and should only be halted if there is a high suspicion that the dialysate itself is the culprit. We suspect the dialysate is a cause of acute pancreatitis if the dialysis prescription had been recently changed preceding the onset of symptoms, particularly if the new prescription includes exchanges with high dextrose-containing dialysate (ie, 4.25 percent dextrose) or <a href=\"topic.htm?path=icodextrin-drug-information\" class=\"drug drug_general\">icodextrin</a>. In such patients, we discontinue the 4.25 percent dextrose or icodextrin dialysate and continue peritoneal dialysis using a lower concentration of dextrose (ie, 1.25 or 2.5 percent dextrose). Peritoneal lavage can be helpful in removing inflammatory mediators. In addition, studies suggest that discontinuation of peritoneal dialysis does not improve outcomes in patients with acute pancreatitis [<a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/28\" class=\"abstract_t\">28</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Prognosis</strong> &ndash; Some reports suggest that dialysis patients with acute pancreatitis have a worse prognosis as compared with those without renal disease [<a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/18,22,28\" class=\"abstract_t\">18,22,28</a>]. In one study, dialysis patients had an increased incidence of pseudocyst formation and a higher mortality compared with patients with alcohol-related pancreatitis [<a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/22\" class=\"abstract_t\">22</a>]. However, morbidity and mortality due to acute pancreatitis appear to be similar in patients undergoing hemodialysis or peritoneal dialysis [<a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/29\" class=\"abstract_t\">29</a>].</p><p/><p class=\"headingAnchor\" id=\"H589357190\"><span class=\"h2\">Exocrine pancreatic insufficiency/chronic pancreatitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>ESRD has been implicated as a risk for chronic pancreatitis, possibly due direct uremic toxicity. It is unclear if the prevalence of chronic pancreatitis is increased in hemodialysis patients; however, exocrine pancreatic insufficiency appears to be frequent in patients on hemodialysis [<a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/30\" class=\"abstract_t\">30</a>]. In one study that included 50 patients with ESRD and no history of acute or chronic pancreatitis, mild-to-moderate exocrine pancreatic insufficiency was reported in 10 percent. All patients had either mild-to-moderate exocrine pancreatic insufficiency with symptoms of diarrhea or steatorrhea. (See <a href=\"topic.htm?path=exocrine-pancreatic-insufficiency\" class=\"medical medical_review\">&quot;Exocrine pancreatic insufficiency&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2671891825\"><span class=\"h1\">SMALL INTESTINE AND COLON</span></p><p class=\"headingAnchor\" id=\"H23\"><span class=\"h2\">Intestinal ischemia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Mesenteric and colonic ischemia in the setting of hemodialysis is typically nonocclusive [<a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/31\" class=\"abstract_t\">31</a>]. Risk factors in patients with end-stage renal disease (ESRD) include older age, peripheral vascular disease, and hypotension during hemodialysis. (See <a href=\"topic.htm?path=nonocclusive-mesenteric-ischemia#H13777672\" class=\"medical medical_review\">&quot;Nonocclusive mesenteric ischemia&quot;, section on 'Epidemiology and risk factors'</a>.)</p><p>Patients with nonocclusive mesenteric ischemia may be asymptomatic or present with mild abdominal pain, bloating, nausea, or vomiting [<a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/32-34\" class=\"abstract_t\">32-34</a>]. Patients with acute colonic ischemia usually present with rapid onset of mild cramping abdominal pain. Rectal bleeding or bloody diarrhea usually develops within 24 hours. Patients on dialysis have more severe ischemic colitis and right-sided colitis as compared with nondialysis patients [<a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/35\" class=\"abstract_t\">35</a>]. (See <a href=\"topic.htm?path=nonocclusive-mesenteric-ischemia#H599416\" class=\"medical medical_review\">&quot;Nonocclusive mesenteric ischemia&quot;, section on 'Clinical features'</a> and <a href=\"topic.htm?path=colonic-ischemia#H278244257\" class=\"medical medical_review\">&quot;Colonic ischemia&quot;, section on 'Acute colonic ischemia'</a>.)</p><p>Among patients undergoing peritoneal dialysis, the symptoms of ischemia may mimic those of peritonitis, resulting in delay in diagnosis and a high mortality [<a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/36,37\" class=\"abstract_t\">36,37</a>]. The diagnostic evaluation and treatment of patients with ischemic colitis and mesenteric ischemia are similar to the nondialysis population and are discussed in detail separately. (See <a href=\"topic.htm?path=colonic-ischemia#H16\" class=\"medical medical_review\">&quot;Colonic ischemia&quot;, section on 'Diagnosis'</a>.)</p><p class=\"headingAnchor\" id=\"H26\"><span class=\"h2\">Constipation/fecal impaction</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Constipation and fecal impaction can occur secondary to the use of phosphate binders, analgesics, and iron in patients on dialysis. Patients with a history of constipation should be advised to avoid aluminum-containing antacids and analgesics to reduce the risk of recurrent fecal impaction. The management of constipation in dialysis patients is similar to the general population with the exception that magnesium and phosphate-containing laxatives are contraindicated in patients with renal failure. The management of fecal impaction and constipation are discussed separately. (See <a href=\"topic.htm?path=constipation-in-the-older-adult#H152272\" class=\"medical medical_review\">&quot;Constipation in the older adult&quot;, section on 'Management'</a>.)</p><p class=\"headingAnchor\" id=\"H28\"><span class=\"h2\">Acute diverticulitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The prevalence of diverticulosis is not increased in dialysis patients, except for those with underlying polycystic kidney disease [<a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/38-40\" class=\"abstract_t\">38-40</a>]. However, the risk of acute diverticulitis may be increased in patients with ESRD [<a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/41\" class=\"abstract_t\">41</a>]. The clinical presentation, diagnosis, and management of acute diverticulitis are the same as with non-ESRD patients. However, operative resection for diverticulitis is associated with a high mortality in older patients with ESRD [<a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/42\" class=\"abstract_t\">42</a>]. (See <a href=\"topic.htm?path=extrarenal-manifestations-of-autosomal-dominant-polycystic-kidney-disease\" class=\"medical medical_review\">&quot;Extrarenal manifestations of autosomal dominant polycystic kidney disease&quot;</a> and <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-acute-diverticulitis-in-adults\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of acute diverticulitis in adults&quot;</a> and <a href=\"topic.htm?path=acute-colonic-diverticulitis-medical-management\" class=\"medical medical_review\">&quot;Acute colonic diverticulitis: Medical management&quot;</a>.)</p><p>The incidence of fecal peritonitis is increased in all adult patients undergoing chronic peritoneal dialysis. Recurrent diverticulitis is a relative contraindication to peritoneal dialysis. However, if peritoneal dialysis is a preferred option for other reasons (ie, distance to hemodialysis center, poor vascular access, severe heart failure), then the <span class=\"nowrap\">risk/benefit</span> discussion should include a discussion of fecal peritonitis. (See <a href=\"topic.htm?path=dialysis-modality-and-patient-outcome#H2\" class=\"medical medical_review\">&quot;Dialysis modality and patient outcome&quot;, section on 'Selection of dialysis modality'</a> and <a href=\"topic.htm?path=patient-survival-and-maintenance-dialysis#H16\" class=\"medical medical_review\">&quot;Patient survival and maintenance dialysis&quot;, section on 'Peritoneal dialysis'</a>.)</p><p>A history of acute diverticulitis is an important consideration in transplant candidates since colonic perforation due to diverticulitis is associated with a high mortality [<a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/39\" class=\"abstract_t\">39</a>]. In patients with indications for surgery (eg, extensive <span class=\"nowrap\">and/or</span> recurrent symptomatic diverticular disease), resection is often performed electively prior to transplant. (See <a href=\"topic.htm?path=evaluation-of-the-potential-renal-transplant-recipient#H119949057\" class=\"medical medical_review\">&quot;Evaluation of the potential renal transplant recipient&quot;, section on 'Gastrointestinal disease'</a>.)</p><p class=\"headingAnchor\" id=\"H4037757573\"><span class=\"h2\">Other rare gastrointestinal diseases</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Dialysis-related gastrointestinal amyloidosis &ndash;</strong> Dialysis-related amyloidosis is rare and is related to the length of time on dialysis [<a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/43\" class=\"abstract_t\">43</a>]. GI manifestations include GI bleeding, ischemic bowel perforation, and colonic pseudo-obstruction. (See <a href=\"topic.htm?path=dialysis-related-amyloidosis\" class=\"medical medical_review\">&quot;Dialysis-related amyloidosis&quot;</a> and <a href=\"topic.htm?path=gastrointestinal-amyloidosis-clinical-manifestations-diagnosis-and-management\" class=\"medical medical_review\">&quot;Gastrointestinal amyloidosis: Clinical manifestations, diagnosis, and management&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Intestinal necrosis &ndash;</strong> <a href=\"topic.htm?path=sodium-polystyrene-sulfonate-drug-information\" class=\"drug drug_general\">Sodium polystyrene sulfonate</a> (SPSS), a cation exchange resin commonly used for the treatment of hyperkalemia in patients with renal failure, has been associated with intestinal necrosis. SPSS associated intestinal necrosis is discussed in detail separately. (See <a href=\"topic.htm?path=treatment-and-prevention-of-hyperkalemia-in-adults#H13\" class=\"medical medical_review\">&quot;Treatment and prevention of hyperkalemia in adults&quot;, section on 'Do not use SPS or other resins'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Spontaneous colonic perforation &#9472;</strong> Among ESRD patients, spontaneous colonic perforation can occur in association with aluminum-containing antacids, <a href=\"topic.htm?path=barium-drug-information\" class=\"drug drug_general\">barium</a> contrast, fecal impaction, or dehydration [<a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/44,45\" class=\"abstract_t\">44,45</a>]. However, the etiology is unknown in many dialysis patients. The diagnosis must be considered in patients presenting with acute abdominal pain. (See <a href=\"topic.htm?path=overview-of-gastrointestinal-tract-perforation#H1137409135\" class=\"medical medical_review\">&quot;Overview of gastrointestinal tract perforation&quot;, section on 'Risk factors'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Uremic colitis &ndash;</strong> Prior to the availability of maintenance dialysis, autopsy studies of patients with untreated uremia revealed extensive colonic ulcerations and pseudomembranes [<a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/44,46\" class=\"abstract_t\">44,46</a>]. These findings, which were termed uremic colitis, are now rarely observed among hemodialysis patients.</p><p/><p class=\"headingAnchor\" id=\"H597374297\"><span class=\"h2\">Bowel preparation for lower gastrointestinal endoscopy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Bowel preparation with hyperosmotic laxative regimens (eg, <a href=\"topic.htm?path=sodium-phosphate-drug-information\" class=\"drug drug_general\">sodium phosphate</a> or <a href=\"topic.htm?path=magnesium-citrate-drug-information\" class=\"drug drug_general\">magnesium citrate</a>) should be avoided in dialysis patients. Such preparations can raise serum levels of phosphate or magnesium and provoke further loss of residual renal function. Recommended preparations in patients with renal insufficiency (eg, polyethylene glycol-electrolyte lavage solution) are discussed in detail separately. (See <a href=\"topic.htm?path=bowel-preparation-before-colonoscopy-in-adults#H149537236\" class=\"medical medical_review\">&quot;Bowel preparation before colonoscopy in adults&quot;, section on 'Patients with heart failure, renal insufficiency, end-stage liver disease, or electrolyte imbalances'</a>.)</p><p class=\"headingAnchor\" id=\"H229973471\"><span class=\"h1\">LIVER</span></p><p class=\"headingAnchor\" id=\"H30\"><span class=\"h2\">Hemodialysis-associated ascites</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients on maintenance hemodialysis can develop ascites in the absence of any other clear underlying cause.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Epidemiology </strong>&ndash; The incidence of hemodialysis-associated ascites is not well established but appears to have declined due to improvement in hemodialysis technology, better control of volume overload, enhanced dialysis dose, and better nutrition.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Pathogenesis and risk factors</strong> &ndash; Although the pathogenesis of hemodialysis-associated ascites is unclear, possible mechanisms include chronic volume overload with hepatic congestion and increased hepatic vein hydrostatic pressure, changes in the permeability of the peritoneal membrane in patients previously on peritoneal dialysis, and impaired lymphatic peritoneal resorption. Other contributing factors include hypoalbuminemia, congestive heart failure, and hyperparathyroidism [<a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/47-51\" class=\"abstract_t\">47-51</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Clinical features and diagnosis</strong> &ndash; Clinical features include abdominal distension, cachexia, and symptoms of volume overload (eg, weight gain, shortness of breath, early satiety, and dyspnea) and malnutrition.</p><p/><p class=\"bulletIndent1\">Ascitic fluid in patients with hemodialysis-associated ascites is clear and has a high protein content (3 to 6 <span class=\"nowrap\">g/dL)</span> with a low ascites albumin gradient (&lt;1.1) and neutrophil count. The diagnosis of hemodialysis-associated ascites is one of exclusion and requires an evaluation to rule out other causes of ascites. This evaluation is discussed in detail separately. (See <a href=\"topic.htm?path=evaluation-of-adults-with-ascites\" class=\"medical medical_review\">&quot;Evaluation of adults with ascites&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Management</strong> &ndash; The initial management of hemodialysis-associated ascites includes volume control with salt and fluid restriction, aggressive fluid removal by ultrafiltration, intermittent paracentesis, and improved nutritional intake [<a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/52\" class=\"abstract_t\">52</a>]. However, hypotension may be a limiting factor in some patients. (See <a href=\"topic.htm?path=ascites-in-adults-with-cirrhosis-initial-therapy\" class=\"medical medical_review\">&quot;Ascites in adults with cirrhosis: Initial therapy&quot;</a>.)</p><p/><p class=\"bulletIndent1\">If these initial measures fail to provide substantial benefit, switching to continuous ambulatory peritoneal dialysis (CAPD) may reduce the severity of ascites and improve nutritional status. Limited data suggest that placement of a peritoneovenous shunt (Denver or LeVeen shunt) may result in an improvement in hemodynamic stability and nutritional status and a reduction of ascites [<a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/53,54\" class=\"abstract_t\">53,54</a>]. However, major complications of peritoneovenous shunt include infections and malfunction. (See <a href=\"topic.htm?path=hepatorenal-syndrome#H18\" class=\"medical medical_review\">&quot;Hepatorenal syndrome&quot;, section on 'Peritoneovenous shunt'</a>.)</p><p/><p class=\"bulletIndent1\">Dialysis-associated ascites has a poor prognosis with a mortality rate of 45 percent within 15 months of diagnosis [<a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/55,56\" class=\"abstract_t\">55,56</a>]. Renal transplantation is the only definitive treatment, and complete resolution of ascites has been reported to occur within six weeks of transplantation in almost all patients [<a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/57,58\" class=\"abstract_t\">57,58</a>]. However, not all transplant centers will perform transplantation in patients with recurrent ascites. (See <a href=\"topic.htm?path=ascites-in-adults-with-cirrhosis-diuretic-resistant-ascites\" class=\"medical medical_review\">&quot;Ascites in adults with cirrhosis: Diuretic-resistant ascites&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H1664895228\"><span class=\"h2\">Hepatitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The epidemiology, diagnosis, and treatment of hepatitis B virus and hepatitis C virus infection among patients on dialysis are discussed elsewhere. (See <a href=\"topic.htm?path=hepatitis-c-virus-infection-in-patients-on-maintenance-dialysis\" class=\"medical medical_review\">&quot;Hepatitis C virus infection in patients on maintenance dialysis&quot;</a> and <a href=\"topic.htm?path=treatment-of-chronic-hepatitis-c-infection-in-adults-with-renal-impairment#H51072120\" class=\"medical medical_review\">&quot;Treatment of chronic hepatitis C infection in adults with renal impairment&quot;, section on 'Severe renal impairment or dialysis'</a> and <a href=\"topic.htm?path=hepatitis-b-virus-and-dialysis-patients\" class=\"medical medical_review\">&quot;Hepatitis B virus and dialysis patients&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H835986386\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Gastrointestinal (GI) angiodysplasias account for approximately 20 and 30 percent of episodes of upper and lower GI bleeding in patients with end-stage renal disease (ESRD). (See <a href=\"#H2568298620\" class=\"local\">'Angiodysplasia'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hemodialysis patients can develop varices in the upper esophagus from superior vena cava (SVC) obstruction due to upper-extremity hemodialysis access. Patients may be asymptomatic and discovered incidentally or present with upper GI bleeding. Definitive management involves treatment of the underlying SVC obstruction. However, in patients with severe upper GI bleeding, endoscopic therapy with variceal band ligation or sclerotherapy at the proximal end of the varix may be needed to temporize bleeding prior to definitive treatment. (See <a href=\"#H4145135415\" class=\"local\">'Esophageal varices'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The prevalence of gastroparesis in ESRD is higher as compared with the general population, possibly due to a higher prevalence of diabetes and the use of medications that affect gastric emptying. As symptoms of gastroparesis are similar to those of uremia, the dialysis prescription and delivered dialysis dose should be assessed prior to performing an extensive evaluation for gastroparesis. In addition, all medications should be carefully reviewed and culprit medications discontinued. (See <a href=\"#H980967562\" class=\"local\">'Gastroparesis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Dialysis patients have a higher risk of acute pancreatitis and a more severe clinical course. Risk factors for acute pancreatitis that are more prevalent in patients with ESRD include hypercalcemia due to hyperparathyroidism. In patients on peritoneal dialysis, risk may be increased by chronic local exposure to specific peritoneal dialysate solutions (eg, 4.25 percent dextrose and <a href=\"topic.htm?path=icodextrin-drug-information\" class=\"drug drug_general\">icodextrin</a>). (See <a href=\"#H695430209\" class=\"local\">'Acute pancreatitis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mesenteric and colonic ischemia in the setting of hemodialysis is typically nonocclusive and is frequently due to underlying hemodialysis-induced hypotension. Patients on dialysis have more severe ischemic colitis and right-sided colitis as compared with nondialysis patients. Among patients undergoing peritoneal dialysis, the symptoms of ischemia may mimic those of peritonitis. (See <a href=\"#H23\" class=\"local\">'Intestinal ischemia'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Constipation and fecal impaction can occur secondary to the use of phosphate binders, analgesics, and iron. Magnesium and phosphate-containing laxative are contraindicated in patients with ESRD. (See <a href=\"#H26\" class=\"local\">'Constipation/fecal impaction'</a> above and <a href=\"#H597374297\" class=\"local\">'Bowel preparation for lower gastrointestinal endoscopy'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients on maintenance hemodialysis can develop ascites in the absence of any other clear underlying cause. The diagnosis of hemodialysis-associated ascites is one of exclusion and requires an evaluation to rule out other causes of ascites. The initial management includes volume control with salt and fluid restriction, aggressive fluid removal by ultrafiltration, intermittent paracentesis, and improved nutritional intake. If initial measures fail, options include switching to continuous ambulatory peritoneal dialysis (CAPD) and placement of a peritoneovenous shunt. Renal transplantation is the only definitive treatment. (See <a href=\"#H30\" class=\"local\">'Hemodialysis-associated ascites'</a> above.)</p><p/><p class=\"headingAnchor\" id=\"H4059183177\"><span class=\"h1\">ACKNOWLEDGMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The editorial staff at UpToDate would like to acknowledge Yousri M Barri, MD, who contributed to earlier versions of this topic review.</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/1\" class=\"nounderline abstract_t\">Hammer J, Oesterreicher C, Hammer K, et al. Chronic gastrointestinal symptoms in hemodialysis patients. Wien Klin Wochenschr 1998; 110:287.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/2\" class=\"nounderline abstract_t\">Chong VH. Impact of duration of hemodialysis on gastrointestinal symptoms in patients with end stage renal failure. J Gastrointestin Liver Dis 2010; 19:462.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/3\" class=\"nounderline abstract_t\">Van Vlem B, Schoonjans R, Vanholder R, et al. Delayed gastric emptying in dyspeptic chronic hemodialysis patients. Am J Kidney Dis 2000; 36:962.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/4\" class=\"nounderline abstract_t\">Zuckerman GR, Cornette GL, Clouse RE, Harter HR. Upper gastrointestinal bleeding in patients with chronic renal failure. Ann Intern Med 1985; 102:588.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/5\" class=\"nounderline abstract_t\">Navab F, Masters P, Subramani R, et al. Angiodysplasia in patients with renal insufficiency. Am J Gastroenterol 1989; 84:1297.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/6\" class=\"nounderline abstract_t\">Chalasani N, Cotsonis G, Wilcox CM. Upper gastrointestinal bleeding in patients with chronic renal failure: role of vascular ectasia. Am J Gastroenterol 1996; 91:2329.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/7\" class=\"nounderline abstract_t\">Alvarez L, Puleo J, Balint JA. Investigation of gastrointestinal bleeding in patients with end stage renal disease. Am J Gastroenterol 1993; 88:30.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/8\" class=\"nounderline abstract_t\">Bronner MH, Pate MB, Cunningham JT, Marsh WH. Estrogen-progesterone therapy for bleeding gastrointestinal telangiectasias in chronic renal failure. An uncontrolled trial. Ann Intern Med 1986; 105:371.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/9\" class=\"nounderline abstract_t\">Richardson JD, Lordon RE. Gastrointestinal bleeding caused by angiodysplasia: a difficult problem in patients with chronic renal failure receiving hemodialysis therapy. Am Surg 1993; 59:636.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/10\" class=\"nounderline abstract_t\">Blam ME, Kobrin S, Siegelman ES, Scotiniotis IA. &quot;Downhill&quot; esophageal varices as an iatrogenic complication of upper extremity hemodialysis access. Am J Gastroenterol 2002; 97:216.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/11\" class=\"nounderline abstract_t\">Chandra A, Tso R, Cynamon J, Miller G. Massive upper GI bleeding in a long-term hemodialysis patient. Chest 2005; 128:1868.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/12\" class=\"nounderline abstract_t\">Loudin M, Anderson S, Schlansky B. Bleeding 'downhill' esophageal varices associated with benign superior vena cava obstruction: case report and literature review. BMC Gastroenterol 2016; 16:134.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/13\" class=\"nounderline abstract_t\">Keshavarzian A, Iber FL. Gastrointestinal involvement in insulin-requiring diabetes mellitus. J Clin Gastroenterol 1987; 9:685.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/14\" class=\"nounderline abstract_t\">McNamee PT, Moore GW, McGeown MG, et al. Gastric emptying in chronic renal failure. Br Med J (Clin Res Ed) 1985; 291:310.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/15\" class=\"nounderline abstract_t\">Ross EA, Koo LC. Improved nutrition after the detection and treatment of occult gastroparesis in nondiabetic dialysis patients. Am J Kidney Dis 1998; 31:62.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/16\" class=\"nounderline abstract_t\">Chen HJ, Wang JJ, Tsay WI, et al. Epidemiology and outcome of acute pancreatitis in end-stage renal disease dialysis patients: a 10-year national cohort study. Nephrol Dial Transplant 2017.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/17\" class=\"nounderline abstract_t\">Padilla B, Pollak VE, Pesce A, et al. Pancreatitis in patients with end-stage renal disease. Medicine (Baltimore) 1994; 73:8.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/18\" class=\"nounderline abstract_t\">Rutsky EA, Robards M, Van Dyke JA, Rostand SG. Acute pancreatitis in patients with end-stage renal disease without transplantation. Arch Intern Med 1986; 146:1741.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/19\" class=\"nounderline abstract_t\">Caruana RJ, Wolfman NT, Karstaedt N, Wilson DJ. Pancreatitis: an important cause of abdominal symptoms in patients on peritoneal dialysis. Am J Kidney Dis 1986; 7:135.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/20\" class=\"nounderline abstract_t\">Bruno MJ, van Westerloo DJ, van Dorp WT, et al. Acute pancreatitis in peritoneal dialysis and haemodialysis: risk, clinical course, outcome, and possible aetiology. Gut 2000; 46:385.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/21\" class=\"nounderline abstract_t\">Lankisch PG, Weber-Dany B, Maisonneuve P, Lowenfels AB. Frequency and severity of acute pancreatitis in chronic dialysis patients. Nephrol Dial Transplant 2008; 23:1401.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/22\" class=\"nounderline abstract_t\">Joglar FM, Saad&eacute; M. Outcome of pancreatitis in CAPD and HD patients. Perit Dial Int 1995; 15:264.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/23\" class=\"nounderline abstract_t\">Moreiras Plaza M, Rodr&iacute;guez Goyanes G, Cui&ntilde;a L, Alonso R. On the toxicity of valproic-acid. Clin Nephrol 1999; 51:187.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/24\" class=\"nounderline abstract_t\">Kishino T, Nakamura K, Mori H, et al. Acute pancreatitis during haemodialysis. Nephrol Dial Transplant 2005; 20:2012.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/25\" class=\"nounderline abstract_t\">Kheda MF, Szerlip HM. Two cases of iodixanol-induced pancreatitis. NDT Plus 2008; 1:296.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/26\" class=\"nounderline abstract_t\">Rubinstein S, Franjul R, Surana S, Fogel J. Icodextrin-induced acute pancreatitis in a peritoneal dialysis patient: a case report and literature review&#8233;. Clin Nephrol 2016; 86 (2016):283.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/27\" class=\"nounderline abstract_t\">Hayat A, Thaneeru P, Priest P, Wilson R. Recurrent pancreatitis in an icodextrin-based peritoneal dialysis patient. Yet another case report. N Z Med J 2013; 126:67.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/28\" class=\"nounderline abstract_t\">Pannekeet MM, Krediet RT, Boeschoten EW, Arisz L. Acute pancreatitis during CAPD in The Netherlands. Nephrol Dial Transplant 1993; 8:1376.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/29\" class=\"nounderline abstract_t\">Quraishi ER, Goel S, Gupta M, et al. Acute pancreatitis in patients on chronic peritoneal dialysis: an increased risk? Am J Gastroenterol 2005; 100:2288.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/30\" class=\"nounderline abstract_t\">Griesche-Philippi J, Otto J, Schw&ouml;rer H, et al. Exocrine pancreatic function in patients with end-stage renal disease. Clin Nephrol 2010; 74:457.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/31\" class=\"nounderline abstract_t\">Li SY, Chen YT, Chen TJ, et al. Mesenteric ischemia in patients with end-stage renal disease: a nationwide longitudinal study. Am J Nephrol 2012; 35:491.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/32\" class=\"nounderline abstract_t\">Bassilios N, Menoyo V, Berger A, et al. Mesenteric ischaemia in haemodialysis patients: a case/control study. Nephrol Dial Transplant 2003; 18:911.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/33\" class=\"nounderline abstract_t\">Dahlberg PJ, Kisken WA, Newcomer KL, Yutuc WR. Mesenteric ischemia in chronic dialysis patients. Am J Nephrol 1985; 5:327.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/34\" class=\"nounderline abstract_t\">Ori Y, Chagnac A, Schwartz A, et al. Non-occlusive mesenteric ischemia in chronically dialyzed patients: a disease with multiple risk factors. Nephron Clin Pract 2005; 101:c87.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/35\" class=\"nounderline abstract_t\">Flobert C, Cellier C, Berger A, et al. Right colonic involvement is associated with severe forms of ischemic colitis and occurs frequently in patients with chronic renal failure requiring hemodialysis. Am J Gastroenterol 2000; 95:195.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/36\" class=\"nounderline abstract_t\">Wellington JL, Rody K. Acute abdominal emergencies in patients on long-term ambulatory peritoneal dialysis. Can J Surg 1993; 36:522.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/37\" class=\"nounderline abstract_t\">Archodovassilis F, Lagoudiannakis EE, Tsekouras DK, et al. Nonocclusive mesenteric ischemia: a lethal complication in peritoneal dialysis patients. Perit Dial Int 2007; 27:136.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/38\" class=\"nounderline abstract_t\">Scheff RT, Zuckerman G, Harter H, et al. Diverticular disease in patients with chronic renal failure due to polycystic kidney disease. Ann Intern Med 1980; 92:202.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/39\" class=\"nounderline abstract_t\">Church JM, Fazio VW, Braun WE, et al. Perforation of the colon in renal homograft recipients. A report of 11 cases and a review of the literature. Ann Surg 1986; 203:69.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/40\" class=\"nounderline abstract_t\">Galbraith P, Bagg MN, Schabel SI, Rajagopalan PR. Diverticular complications of renal failure. Gastrointest Radiol 1990; 15:259.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/41\" class=\"nounderline abstract_t\">Chang SS, Huang N, Hu HY. Patients with end-stage renal disease were at an increased risk of hospitalization for acute diverticulitis. Medicine (Baltimore) 2016; 95:e4881.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/42\" class=\"nounderline abstract_t\">Moran-Atkin E, Stem M, Lidor AO. Surgery for diverticulitis is associated with high risk of in-hospital mortality and morbidity in older patients with end-stage renal disease. Surgery 2014; 156:361.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/43\" class=\"nounderline abstract_t\">Jimenez RE, Price DA, Pinkus GS, et al. Development of gastrointestinal beta2-microglobulin amyloidosis correlates with time on dialysis. Am J Surg Pathol 1998; 22:729.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/44\" class=\"nounderline abstract_t\">Brown KM. Isolated ascending colon ulceration in a patient with chronic renal insufficiency. J Natl Med Assoc 1992; 84:185.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/45\" class=\"nounderline abstract_t\">Bischel MD, Reese T, Engel J. Spontaneous perforation of the colon in a hemodialysis patient. Am J Gastroenterol 1980; 74:182.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/46\" class=\"nounderline abstract_t\">Milito G, Taccone-Gallucci M, Brancaleone C, et al. The gastrointestinal tract in uremic patients on long-term hemodialysis. Kidney Int Suppl 1985; 17:S157.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/47\" class=\"nounderline abstract_t\">Cintin C, Joffe P. Nephrogenic ascites. Case report and review of the literature. Scand J Urol Nephrol 1994; 28:311.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/48\" class=\"nounderline abstract_t\">Rodriguez HJ, Walls J, Slatopolsky E, Klahr S. Recurrent ascites following peritoneal dialysis. A new syndrome? Arch Intern Med 1974; 134:283.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/49\" class=\"nounderline abstract_t\">Hammond TC, Takiyyuddin MA. Nephrogenic ascites: a poorly understood syndrome. J Am Soc Nephrol 1994; 5:1173.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/50\" class=\"nounderline abstract_t\">Rubin J, Rust P, Brown P, et al. A comparison of peritoneal transport in patients with psoriasis and uremia. Nephron 1981; 29:185.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/51\" class=\"nounderline abstract_t\">Nasr EM, Joubran NI. Is nephrogenic ascites related to secondary hyperparathyroidism? Am J Kidney Dis 2001; 37:E16.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/52\" class=\"nounderline abstract_t\">Gunal AI, Karaca I, Celiker H, et al. Strict volume control in the treatment of nephrogenic ascites. Nephrol Dial Transplant 2002; 17:1248.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/53\" class=\"nounderline abstract_t\">Holm A, Rutsky EA, Aldrete JS. Short- and long-term effectiveness, morbidity, and mortality of peritoneovenous shunt inserted to treat massive refractory ascites of nephrogenic origin analysis of 14 cases. Am Surg 1989; 55:645.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/54\" class=\"nounderline abstract_t\">Morgan AG, Sivapragasam S, Fletcher P, Terry SI. Hemodynamic improvement after peritoneovenous shunting in nephrogenic ascites. South Med J 1982; 75:373.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/55\" class=\"nounderline abstract_t\">Gl&uuml;ck Z, Nolph KD. Ascites associated with end-stage renal disease. Am J Kidney Dis 1987; 10:9.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/56\" class=\"nounderline abstract_t\">Feingold LN, Gutman RA, Walsh FX, Gunnells JC. Control of cachexia and ascites in hemodialysis patients by binephrectomy. Arch Intern Med 1974; 134:989.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/57\" class=\"nounderline abstract_t\">Popli S, Chen WT, Nakamoto S, et al. Hemodialysis ascites in anephric patients. Clin Nephrol 1981; 15:203.</a></li><li><a href=\"https://www.uptodate.com/contents/unique-aspects-of-gastrointestinal-disease-in-dialysis-patients/abstract/58\" class=\"nounderline abstract_t\">Melero M, Rodriguez M, Araque A, et al. Idiopathic dialysis ascites in the nineties: resolution after renal transplantation. Am J Kidney Dis 1995; 26:668.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 1897 Version 18.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H835986386\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H1670291988\" id=\"outline-link-H1670291988\">ESOPHAGUS AND STOMACH</a><ul><li><a href=\"#H2568298620\" id=\"outline-link-H2568298620\">Angiodysplasia</a></li><li><a href=\"#H4145135415\" id=\"outline-link-H4145135415\">Esophageal varices</a></li><li><a href=\"#H980967562\" id=\"outline-link-H980967562\">Gastroparesis</a></li></ul></li><li><a href=\"#H2869713521\" id=\"outline-link-H2869713521\">PANCREAS</a><ul><li><a href=\"#H695430209\" id=\"outline-link-H695430209\">Acute pancreatitis</a></li><li><a href=\"#H589357190\" id=\"outline-link-H589357190\">Exocrine pancreatic insufficiency/chronic pancreatitis</a></li></ul></li><li><a href=\"#H2671891825\" id=\"outline-link-H2671891825\">SMALL INTESTINE AND COLON</a><ul><li><a href=\"#H23\" id=\"outline-link-H23\">Intestinal ischemia</a></li><li><a href=\"#H26\" id=\"outline-link-H26\">Constipation/fecal impaction</a></li><li><a href=\"#H28\" id=\"outline-link-H28\">Acute diverticulitis</a></li><li><a href=\"#H4037757573\" id=\"outline-link-H4037757573\">Other rare gastrointestinal diseases</a></li><li><a href=\"#H597374297\" id=\"outline-link-H597374297\">Bowel preparation for lower gastrointestinal endoscopy</a></li></ul></li><li><a href=\"#H229973471\" id=\"outline-link-H229973471\">LIVER</a><ul><li><a href=\"#H30\" id=\"outline-link-H30\">Hemodialysis-associated ascites</a></li><li><a href=\"#H1664895228\" id=\"outline-link-H1664895228\">Hepatitis</a></li></ul></li><li><a href=\"#H835986386\" id=\"outline-link-H835986386\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#H4059183177\" id=\"outline-link-H4059183177\">ACKNOWLEDGMENT</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=acute-colonic-diverticulitis-medical-management\" class=\"medical medical_review\">Acute colonic diverticulitis: Medical management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=angiodysplasia-of-the-gastrointestinal-tract\" class=\"medical medical_review\">Angiodysplasia of the gastrointestinal tract</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-acute-upper-gastrointestinal-bleeding-in-adults\" class=\"medical medical_review\">Approach to acute upper gastrointestinal bleeding in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-the-patient-with-elevated-serum-amylase-or-lipase\" class=\"medical medical_review\">Approach to the patient with elevated serum amylase or lipase</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=ascites-in-adults-with-cirrhosis-diuretic-resistant-ascites\" class=\"medical medical_review\">Ascites in adults with cirrhosis: Diuretic-resistant ascites</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=ascites-in-adults-with-cirrhosis-initial-therapy\" class=\"medical medical_review\">Ascites in adults with cirrhosis: Initial therapy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=bowel-preparation-before-colonoscopy-in-adults\" class=\"medical medical_review\">Bowel preparation before colonoscopy in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=central-vein-stenosis-associated-with-hemodialysis-access\" class=\"medical medical_review\">Central vein stenosis associated with hemodialysis access</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-acute-diverticulitis-in-adults\" class=\"medical medical_review\">Clinical manifestations and diagnosis of acute diverticulitis in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-acute-pancreatitis\" class=\"medical medical_review\">Clinical manifestations and diagnosis of acute pancreatitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-peritonitis-in-peritoneal-dialysis\" class=\"medical medical_review\">Clinical manifestations and diagnosis of peritonitis in peritoneal dialysis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=colonic-ischemia\" class=\"medical medical_review\">Colonic ischemia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=constipation-in-the-older-adult\" class=\"medical medical_review\">Constipation in the older adult</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=dialysis-modality-and-patient-outcome\" class=\"medical medical_review\">Dialysis modality and patient outcome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=dialysis-related-amyloidosis\" class=\"medical medical_review\">Dialysis-related amyloidosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=etiology-of-acute-pancreatitis\" class=\"medical medical_review\">Etiology of acute pancreatitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=evaluation-of-adults-with-ascites\" class=\"medical medical_review\">Evaluation of adults with ascites</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=evaluation-of-the-potential-renal-transplant-recipient\" class=\"medical medical_review\">Evaluation of the potential renal transplant recipient</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=exocrine-pancreatic-insufficiency\" class=\"medical medical_review\">Exocrine pancreatic insufficiency</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=extrarenal-manifestations-of-autosomal-dominant-polycystic-kidney-disease\" class=\"medical medical_review\">Extrarenal manifestations of autosomal dominant polycystic kidney disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=gastrointestinal-amyloidosis-clinical-manifestations-diagnosis-and-management\" class=\"medical medical_review\">Gastrointestinal amyloidosis: Clinical manifestations, diagnosis, and management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=gastroparesis-etiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Gastroparesis: Etiology, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hepatitis-b-virus-and-dialysis-patients\" class=\"medical medical_review\">Hepatitis B virus and dialysis patients</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hepatitis-c-virus-infection-in-patients-on-maintenance-dialysis\" class=\"medical medical_review\">Hepatitis C virus infection in patients on maintenance dialysis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hepatorenal-syndrome\" class=\"medical medical_review\">Hepatorenal syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hypertriglyceridemia-induced-acute-pancreatitis\" class=\"medical medical_review\">Hypertriglyceridemia-induced acute pancreatitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=indications-for-initiation-of-dialysis-in-chronic-kidney-disease\" class=\"medical medical_review\">Indications for initiation of dialysis in chronic kidney disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=malignancy-related-superior-vena-cava-syndrome\" class=\"medical medical_review\">Malignancy-related superior vena cava syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=noninfectious-complications-of-continuous-peritoneal-dialysis\" class=\"medical medical_review\">Noninfectious complications of continuous peritoneal dialysis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=nonocclusive-mesenteric-ischemia\" class=\"medical medical_review\">Nonocclusive mesenteric ischemia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-gastrointestinal-tract-perforation\" class=\"medical medical_review\">Overview of gastrointestinal tract perforation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-the-management-of-chronic-kidney-disease-in-adults\" class=\"medical medical_review\">Overview of the management of chronic kidney disease in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=patient-survival-and-maintenance-dialysis\" class=\"medical medical_review\">Patient survival and maintenance dialysis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=peritoneal-dialysis-solutions\" class=\"medical medical_review\">Peritoneal dialysis solutions</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=platelet-dysfunction-in-uremia\" class=\"medical medical_review\">Platelet dysfunction in uremia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=serum-enzymes-in-patients-with-renal-failure\" class=\"medical medical_review\">Serum enzymes in patients with renal failure</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-and-prevention-of-hyperkalemia-in-adults\" class=\"medical medical_review\">Treatment and prevention of hyperkalemia in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-chronic-hepatitis-c-infection-in-adults-with-renal-impairment\" class=\"medical medical_review\">Treatment of chronic hepatitis C infection in adults with renal impairment</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-gastroparesis\" class=\"medical medical_review\">Treatment of gastroparesis</a></li></ul></div></div>","javascript":null}